Health-Related Quality-of-Life (HRQoL) in Patients (pts) with Advanced Neuroendocrine Tumors (NET) Treated with Everolimus (EVE): Results from an Open-Label, Phase IIIb, Multicenter, Expanded Access Program (EAP)
NEUROENDOCRINOLOGY（2014）
Key words
everolimus,qol,net
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined